Skip to content
10-Q

Quarterly Report

Bohai Pharmaceuticals Group, Inc.

0001511164-14-000263

← back to feed
Filed
May 15, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2014 · Mar 31, 2014 21.83M sh
Shares Diluted Q3 2014 · Mar 31, 2014 21.96M sh
Shares Diluted Q3 2014 · Mar 31, 2013 22.09M sh
Shares Diluted Q3 2014 · Mar 31, 2013 22.09M sh
Shares Outstanding Q3 2014 · Mar 31, 2014 17.86M sh
Capex Q3 2014 · Mar 31, 2014 −$195.19K
Capex restated Q3 2014 · Mar 31, 2013 −$781.18K
Operating Cash Flow Q3 2014 · Mar 31, 2014 $12.82M
Operating Cash Flow Q3 2014 · Mar 31, 2013 $7.87M
Short Term Debt Q3 2014 · Mar 31, 2014 $4.87M
Short Term Debt Q3 2014 · Jun 30, 2013 $0
Cash And Equivalents Q3 2014 · Mar 31, 2014 $11.27M
Cash And Equivalents Q3 2014 · Jun 30, 2013 $6.95M
Cash And Equivalents Q3 2014 · Mar 31, 2013 $3.76M
Cash And Equivalents Q3 2014 · Jun 30, 2012 $18.39M
Stockholders Equity Q3 2014 · Mar 31, 2014 $126.49M
Stockholders Equity Q3 2014 · Jun 30, 2013 $108.39M
Current Liabilities Q3 2014 · Mar 31, 2014 $33.68M
Current Liabilities Q3 2014 · Jun 30, 2013 $35.72M
Total Liabilities Q3 2014 · Mar 31, 2014 $49.22M
Total Liabilities Q3 2014 · Jun 30, 2013 $57.23M
Current Assets Q3 2014 · Mar 31, 2014 $75.82M
Current Assets Q3 2014 · Jun 30, 2013 $62.03M
Total Assets Q3 2014 · Mar 31, 2014 $175.71M
Total Assets Q3 2014 · Jun 30, 2013 $165.62M
Eps Diluted Q3 2014 · Mar 31, 2014 $0.19
Eps Diluted Q3 2014 · Mar 31, 2014 $0.85
Eps Diluted Q3 2014 · Mar 31, 2013 $0.15
Eps Diluted Q3 2014 · Mar 31, 2013 $0.71
Eps Basic Q3 2014 · Mar 31, 2014 $0.22
Eps Basic Q3 2014 · Mar 31, 2014 $1.01
Eps Basic Q3 2014 · Mar 31, 2013 $0.18
Eps Basic Q3 2014 · Mar 31, 2013 $0.83
Sga Expense Q3 2014 · Mar 31, 2014 $23.1M
Sga Expense Q3 2014 · Mar 31, 2014 $70.35M
Sga Expense Q3 2014 · Mar 31, 2013 $20.48M
Sga Expense Q3 2014 · Mar 31, 2013 $60.23M
Rd Expense Q3 2014 · Mar 31, 2014 $25.7K
Rd Expense Q3 2014 · Mar 31, 2014 $88.45K
Rd Expense Q3 2014 · Mar 31, 2013 $2K
Rd Expense restated Q3 2014 · Mar 31, 2013 $5.99K
Net Income Q3 2014 · Mar 31, 2014 $3.93M
Net Income Q3 2014 · Mar 31, 2014 $18.02M
Net Income Q3 2014 · Mar 31, 2013 $3.16M
Net Income Q3 2014 · Mar 31, 2013 $14.81M
Operating Income Q3 2014 · Mar 31, 2014 $5.77M
Operating Income Q3 2014 · Mar 31, 2014 $25.9M
Operating Income Q3 2014 · Mar 31, 2013 $4.65M
Operating Income Q3 2014 · Mar 31, 2013 $19.96M
Gross Profit Q3 2014 · Mar 31, 2014 $29.6M
Gross Profit Q3 2014 · Mar 31, 2014 $98.41M
Gross Profit restated Q3 2014 · Mar 31, 2013 $25.87M
Gross Profit restated Q3 2014 · Mar 31, 2013 $83.97M
Cost Of Revenue Q3 2014 · Mar 31, 2014 $10.13M
Cost Of Revenue Q3 2014 · Mar 31, 2014 $30.88M
Cost Of Revenue Q3 2014 · Mar 31, 2013 $8.92M
Cost Of Revenue Q3 2014 · Mar 31, 2013 $27.1M
Revenue Q3 2014 · Mar 31, 2014 $39.72M
Revenue Q3 2014 · Mar 31, 2014 $129.28M
Revenue Q3 2014 · Mar 31, 2013 $34.79M
Revenue Q3 2014 · Mar 31, 2013 $111.07M